Catalyst Wire Dossier Catalyst Wire Dossier

Ofloxacin ophthalmic solution

ofloxacin · Alcon Research
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ofloxacin ophthalmic solution, covering 2015-05-12 to 2015-05-12. Get the full timeline:

Most recent: Clinical Trial Update: An Evaluation of the Safety and Efficacy of Moxifloxacin Ophthalmic Solution 0.5% ((VIGAMOX®) Versus Ofloxacin Ophthalmic Solution 0.3% in the Treatment of Bacterial Conjunctivitis in Chinese Patients [Phase 3]

See pricing